Name | FC9402 |
---|
Description | FC9402 is a potent and selective sulfide quinone oxidoreductase (SQOR) inhibitor extracted from patent WO 2020/146636 A1. FC9402 attenuates TAC-induced cardiomyocyte hypertrophy and left ventricle (LV) fibrosis. FC9402 can be used for cardiovascular regulation[1]. |
---|---|
Related Catalog | |
Target |
SQOR[1] |
In Vitro | FC9402 attenuates TAC-induced cardiomyocyte hypertrophy and left ventricle (LV) fibrosis[1]. |
References |
[1]. WO 2020/146636 A1 |
Molecular Formula | C19H16N4O |
---|---|
Molecular Weight | 316.36 |
Storage condition | 2-8°C |